A novel cancer-associated membrane signature predicts prognosis and therapeutic response for lung adenocarcinoma
Abstract Lung adenocarcinoma (LUAD) is a leading cause of cancer-related death, and reliable biomarkers for prognosis and treatment guidance remain limited. Membrane proteins play key roles in tumor progression and therapeutic response, yet their clinical utility in LUAD remains underexplored. We in...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Portfolio
2025-07-01
|
| Saila: | Scientific Reports |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1038/s41598-025-11105-8 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|